Literature DB >> 7986910

Successful treatment of extensive posttraumatic soft-tissue and renal infections due to Apophysomyces elegans.

P C Okhuysen1, J H Rex, M Kapusta, C Fife.   

Abstract

We describe the clinical course and successful treatment of a previously healthy man who, after experiencing trauma, presented with severe cutaneous mucormycosis due to Apophysomyces elegans and subsequently developed secondary renal infection. A multidisciplinary approach employing aggressive surgical debridement and therapy with hyperbaric oxygen, liposomal amphotericin B, and interferon-gamma was successful in controlling his infection, obviating the need for nephrectomy.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7986910     DOI： 10.1093/clinids/19.2.329

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  10 in total

1.  Invasive Apophysomyces variabilis infection in a burn patient.

Authors:  Wilfred P dela Cruz; Tatjana P Calvano; Matthew E Griffith; Christopher E White; Seung H Kim; Deanna A Sutton; Elizabeth H Thompson; Jianmin Fu; Brian L Wickes; Josep Guarro; Duane R Hospenthal
Journal:  J Clin Microbiol       Date:  2012-05-23       Impact factor: 5.948

Review 2.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  Rhino-orbital-cerebral mucormycosis.

Authors:  Maria N Gamaletsou; Nikolaos V Sipsas; Emmanuel Roilides; Thomas J Walsh
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

4.  Hyperbaric oxygen therapy in a patient with autosomal dominant polycystic kidney disease with a perinephritic abscess.

Authors:  Jorge Vega; Helmuth Goecke; Francisco Manriquez; Carlos Escobar; Max Escobar; Christian Videla; Mario Santamarina; Carlos Echeverria; Francisco Javier Guarda
Journal:  Clin Exp Nephrol       Date:  2010-10-01       Impact factor: 2.801

Review 5.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

6.  Apophysomyces elegans: an emerging zygomycete in India.

Authors:  A Chakrabarti; A Ghosh; G S Prasad; J K David; S Gupta; A Das; V Sakhuja; N K Panda; S K Singh; S Das; T Chakrabarti
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 7.  Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.

Authors:  Kimberly P Liang; Imad M Tleyjeh; Walter R Wilson; Glenn D Roberts; Zelalem Temesgen
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

Review 8.  Severe osteomyelitis due to the zygomycete Apophysomyces elegans.

Authors:  J F Meis; B J Kullberg; M Pruszczynski; R P Veth
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

9.  Primary Cutaneous Mucormycosis in a Trauma Patient with Morel-Lavallée Lesion.

Authors:  Karan Singla; Tanvir Samra; Nidhi Bhatia
Journal:  Indian J Crit Care Med       Date:  2018-05

10.  Post-traumatic cutaneous mucormycosis in an immunocompetent patient.

Authors:  Y El Deeb; H Al Soub; M Almaslamani; J Al Khuwaiter; S J Taj-Aldeen
Journal:  Ann Saudi Med       Date:  2005 Jul-Aug       Impact factor: 1.526
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.